EP4003289A1 - Kosmetische zusammensetzung, verfahren zur herstellung der kosmetischen zusammensetzung und ihre verwendung - Google Patents

Kosmetische zusammensetzung, verfahren zur herstellung der kosmetischen zusammensetzung und ihre verwendung

Info

Publication number
EP4003289A1
EP4003289A1 EP19752071.1A EP19752071A EP4003289A1 EP 4003289 A1 EP4003289 A1 EP 4003289A1 EP 19752071 A EP19752071 A EP 19752071A EP 4003289 A1 EP4003289 A1 EP 4003289A1
Authority
EP
European Patent Office
Prior art keywords
cosmetic composition
compounds
composition
weight
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19752071.1A
Other languages
English (en)
French (fr)
Inventor
Cyrus ANDRIOLO
Angeles FONOLLA-MORENO
Cintia HARASAWA
Tassia HANASHIRO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andriolo Cyrus
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP4003289A1 publication Critical patent/EP4003289A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes

Definitions

  • the present invention is directed to a cosmetic composition
  • a cosmetic composition comprising
  • the present invention is also related to a process of manufacturing the cosmetic composition and its use.
  • UV ultraviolet
  • UVA/UVB cosmetic compositions used to accomplish photoprotection, namely, inorganic UV filters and organic UV filters.
  • the degree of UV protection afforded by a cosmetic composition is directly related to the amount and type of UV filters contained therein. The higher the amount of UV filters, the greater the degree of UV protection (UVA/UVB).
  • cosmetic compositions must provide good protection against the sun, a measure of which is the Sun Protection Factor (SPF) value, yet have satisfactory sensory perception, such as a smooth but not greasy feel upon application.
  • SPF Sun Protection Factor
  • tinted cosmetic compositions that can provide sunscreen protection to the skin as well as skin color correction, resulting in an effect similar to a make-up foundation, and which do not transfer to other objects or materials after application to the skin, particularly the skin of the face.
  • the inventors developed a cosmetic composition with high SPF, a pigment system and film-forming polymers, which provides a tinted cosmetic composition that transfers as little as possible to other materials and objects after application to the skin, particularly the skin of the face.
  • the present invention is directed to a cosmetic composition
  • a cosmetic composition comprising
  • the present invention is also related to a process of manufacturing the cosmetic composition and its use.
  • the present invention relates to the use of the cosmetic composition for the manufacture of a product to be used as tinted sunscreen daily product.
  • the cosmetic composition of the present invention can comprise, consist of, or consist essentially of the essential elements and limitations of the present invention described herein, as well as any of the additional or optional ingredients, components, or limitations described herein.
  • the cosmetic composition of the present invention comprises:
  • composition according to the invention presents enhanced anti-oiliness properties, high SPF values, dry touch to the skin after application combined with matt effect and no white film formation. Also, the tinted cosmetic composition of the present invention does not transfer or dirties clothes, cell phones and others, leaving the facial skin with a uniform color right after the application and throughout the day.
  • the pigment system is present in an amount ranging from 0.1 % to 10% by weight, preferably in an amount of from about 0.5% to about 8.0% by weight, more preferably about 1 .5% to about 7.0% by weight, most preferably about 2.5% to about 6.5% by weight, based on the total weight of the composition.
  • the pigment system of the present invention comprises coated and uncoated pigments.
  • the amount of coated pigments present is such mixture is from 0.1 % to 10.0% by weight, based on the total weight of the composition, and the amount of uncoated pigments present in such mixture is from 0.1 % to 10.0% by weight, based on the total weight of the composition.
  • the cosmetic composition of the present invention has an amount of UV filter system from about 0.1 % to about 50% by weight, preferably in an amount of from about 5% to about 40% by weight, more preferably about 7.5% to about 30% by weight, most preferably about 10% to about 25% by weight, based on the total weight of the composition.
  • the film forming polymer is present in an amount ranging from 0.5% to 5.0% by weight, preferably in an amount of from about 1 .0% to about 4.5% by weight, more preferably about 1 .5% to about 4.0% by weight, most preferably about 2.0% to about 3.5% by weight based on the total weight of the composition.
  • the film-forming polymer is a mixture of hydrogenated polycyclopentadiene and acrylates copolymer
  • the amount of hydrogenated polycyclopentadiene present is such mixture is from 0.1 % to 3.5% by weight, based on the total weight of the composition
  • the amount of acrylates copolymer present in such mixture is from 0.1 % to 3.5% by weight, based on the total weight of the composition.
  • the pigment system of the present invention comprises coated pigments selected from the group of iron oxide(s) (and) perfluorohexylethyl triethoxysilane, titanium dioxide (and) aluminum hydroxide (and) perfluorohexylethyl triethoxysilane, and combinations thereof.
  • the pigments system of the present invention comprises uncoated pigments selected from the group of titanium dioxide, iron oxide(s) and combinations thereof.
  • the UV filter system of the present invention comprises at least one UV filter selected from the group of inorganic UV filters and organic UV filters, and mixtures thereof.
  • the UV filter system comprises at least one organic UV filter selected from the group consisting of anthranilic compounds; dibenzoylmethane compounds; cinnamic compounds; salicylic compounds; camphor compounds; benzophenone compounds; b,b-diphenylacrylate compounds; triazine compounds; benzotriazole compounds; benzalmalonate compounds; benzimidazole compounds; imidazoline compounds; bis-benzoazolyl compounds; p-aminobenzoic acid (PABA) compounds; methylenebis(hydroxyphenylbenzotriazole) compounds; benzoxazole compounds; screening polymers and screening silicones; dimers derived from a- alkylstyrene; 4,4-diarylbutadienes compounds; guaiazulene and derivatives thereof; rutin and derivatives thereof; flavonoids; bioflavonoids; oryzanol and derivatives thereof; quinic acid and derivatives thereof; phenols; retinol; cyst
  • the UV filter system of the present invention is selected from the group of phenylbenzimidazole sulfonic acid, butyl methoxydibenzoylmethane, titanium dioxide, ethylhexyl triazone, terephthalylidene dicamphor sulfonic acid, octocrylene, homosalate, bis-ethylhexyloxyphenol methoxyphenyl triazine, silica (and) titanium dioxide, methylene bis-benzotriazolyl tetramethylbutylphenol (and) polyglyceryl-10 laurate, and combinations thereof.
  • the film-forming polymer of the present invention is a mixture of hydrogenated polycyclopentadiene and acrylates copolymer.
  • the cosmetic composition of the present invention further comprises cosmetically acceptable ingredients selected from additional sunscreens, perfume/fragrance, preserving agents, solvents, actives, surfactants, fatty compounds, vitamins, fillers, silicones, polymers, pigments, buffering, masking and mixtures thereof.
  • the cosmetic composition of the present invention may present a Sun Protection Factor ranging from 30 to 99.
  • the sunscreen composition of the present invention may present a Sun Protection Factor of 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90 and 99.
  • the cosmetic composition of the present invention may present a Sun Protection Factor of 30.
  • the cosmetic composition of the present invention may present a Sun Protection Factor of 40. In an embodiment, the cosmetic composition of the present invention may present a Sun Protection Factor of 50.
  • the cosmetic composition of the present invention may present a Sun Protection Factor of 60.
  • the cosmetic composition of the present invention may present a Sun Protection Factor of 70.
  • the cosmetic composition of the present invention may present a Sun Protection Factor of 80.
  • the cosmetic composition of the present invention may present a Sun Protection Factor of 90.
  • the cosmetic composition of the present invention may present a Sun Protection Factor of 99.
  • the cosmetic composition of the invention can be used as a daily tinted product for the skin, particularly as a tinted sunscreen.
  • the present invention is directed to a process for manufacturing the cosmetic composition of the present invention.
  • the present invention is related to the use of the cosmetic composition the manufacture of a product to be used as tinted sunscreen daily product.
  • the expression“at least” means one or more and thus includes individual components as well as mixtures/combinations.
  • ranges provided are meant to include every specific range within, and combination of sub ranges between, the given ranges.
  • a range from 1 -5 includes specifically 1 , 2, 3, 4 and 5, as well as sub ranges such as 2-5, 3-5, 2-3, 2-4, 1 -4, etc.
  • All ranges and values disclosed herein are inclusive and combinable. For examples, any value or point described herein that falls within a range described herein can serve as a minimum or maximum value to derive a sub-range, etc.
  • the cosmetic composition of the present invention comprises a pigment system which comprises coated pigments or/and uncoated pigments.
  • Coated pigments are pigments which have undergone one or more surface treatments of a chemical, electronic, mechanochemical and/or mechanical nature with compounds such as those described for example in Cosmetics & Toiletries, February 1990, vol. 105, p.53-64, such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surface-active agents, lecithin, sodium, potassium, zinc, iron or aluminum salts of fatty acids, (titanium or aluminum) metal alkoxides, polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.
  • a chemical, electronic, mechanochemical and/or mechanical nature such as those described for example in Cosmetics & Toiletries, February 1990, vol. 105, p.53-64, such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surface-active agents, lecithin, sodium, potassium, zinc, iron
  • Coated pigments are more particularly titanium oxides coated with silica such as the product, silica and iron oxide, silica and alumina, alumina such as the products, alumina and aluminum stearate, alumina and aluminum laurate, iron oxide and iron stearate, zinc oxide and zinc stearate, silica, alumina and silicone, silica, alumina, aluminum stearate and silicone, alumina and silicone, etc.
  • silica such as the product, silica and iron oxide, silica and alumina, alumina such as the products, alumina and aluminum stearate, alumina and aluminum laurate, iron oxide and iron stearate, zinc oxide and zinc stearate, silica, alumina and silicone, silica, alumina, aluminum stearate and silicone, alumina and silicone, etc.
  • metal oxides may also be mentioned, especially titanium dioxide and cerium dioxide, including the silica-coated equiponderous mixture of titanium dioxide and cerium dioxide, as well as the alumina-silica- and silicone-coated mixture of titanium oxide and zinc dioxide, or the alumina-, silica- and glycerin-coated mixture of titanium dioxide and zinc dioxide.
  • Uncoated pigments like titanium oxides, zinc oxides and cerium oxide may be used in the cosmetic composition of the present invention.
  • Non-limitative examples of uncoated pigments are iron oxides, titanium oxides, zinc oxides and cerium oxide.
  • examples of iron oxides may be yellow, red and black iron oxides.
  • the pigment system of the present invention is present in an amount ranging from 0.1 % to 10% by weight, preferably in an amount of from about 0.5% to about 8.0% by weight, more preferably about 1 .5% to about 7.0% by weight, most preferably about 2.5% to about 6.5% by weight, based on the total weight of the composition.
  • Non-limiting suitable UV filters of the present invention could be as follows:
  • oil-soluble organic sunscreen ingredient means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in an oil phase or which can be dissolved in colloidal form (for example in micellar form) in an oil fatty phase.
  • Non-limiting examples of oil-soluble organic sunscreen ingredients useful in the invention include, for example, cinnamic derivatives; anthranilates; salicylic derivatives; dibenzoylmethane derivatives; camphor derivatives; benzophenone derivatives; diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives, especially those cited in patent US5624663; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives as described in patents EP669323 and US2463264; p-aminobenzoic acid (PABA) derivatives; methylene bis(hydroxyphenylbenzotriazole) derivatives as described in applications US5237071 , US5166355, GB2303549, DE19726184 and EP8931 19; benzoxazole derivatives as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; screening polymers and screening silicones such as
  • cinnamic derivatives include, but are not limited to, ethylhexyl methoxycinnamate, isopropyl methoxycinnamate, isoamyl methoxycinnamate, DEA methoxycinnamate, diisopropyl methylcinnamate, glyceryl ethylhexanoate dimethoxycinnamate.
  • Suitable dibenzoylmethane derivatives include, but are not limited to, butyl methoxydibenzoylmethane and isopropyl dibenzoylmethane.
  • suitable salicylic derivatives include, but are not limited to, homosalate, ethylhexyl salicylate, dipropylene glycol salicylate and TEA salicylate.
  • Beta, beta -Diphenylacrylate derivatives
  • Suitable beta, beta -diphenylacrylate derivatives include, but are not limited to, octocrylene and etocrylene.
  • benzophenone derivatives include, but are not limited to, benzophenone-1 , benzophenone-2, benzophenone-3 or oxybenzone, benzophenone-4, benzophenone-5, benzophenone-6, benzophenone-8, benzophenone-9, benzophenone-12, n-hexyl 2-(4-diethylamino-2- hydroxybenzoyl)benzoate or as a mixture with octyl methoxycinnamate.
  • Suitable benzylidenecamphor derivatives include, but are not limited to, 3-benzylidene camphor manufactured, 4-methylbenzylidene camphor, polyacrylamidomethyl benzylidene camphor manufactured.
  • Suitable phenylbenzotriazole derivatives include, but are not limited to, drometrizole trisiloxane, methylene bis-benzotriazolyl tetramethylbutyl- phenol, or in micronized form as an aqueous dispersion.
  • triazine derivatives include, but are not limited to, bis-ethylhexyloxyphenol methoxyphenyl triazine, ethylhexyl triazone, diethylhexyl butamido triazone, 2,4,6-tris(dineopentyl 4’-aminobenzalmalonate)-s-triazine, 2,4,6- tris(diisobutyl 4’-aminobenzalmalonate)-S triazine, 2,4-bis(dineopentyl 4'- aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s-triazine, symmetrical triazine screening agents described in patent US 6,225,467, patent application WO 2004/085412 (see compounds 6 and 9) or the document "Symmetrical Triazine Derivatives" IP.COM Journal, IP.COM Inc., West Henrietta, NY,
  • An example of a suitable anthranilic derivative includes, but is not limited to, methyl anthranilate.
  • An example of a suitable imidazoline derivative includes, but is not limited to, ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
  • benzalmalonate derivative includes, but is not limited to, polyorganosiloxane containing benzalmalonate functions, for instance polysilicone-15.
  • An example of a suitable 4,4-diarylbutadiene derivative includes, but is not limited to, 1 -Dicarboxy(2,2’-dimethylpropyl)-4, 4-diphenyl-butadiene.
  • benzoxazole derivative includes, but is not limited to, 2,4-bis[5-(1 -dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl) imino-1 ,3,5-triazine, and mixtures thereof.
  • the oil-soluble organic sunscreen ingredient will be chosen from butyl methoxydibenzoylmethane, ethylhexyl salicylate, ethylhexyl triazone, octocrylene, drometrizole trisiloxane, bis-ethylhexyloxyphenol methoxyphenyl triazine, and mixtures thereof.
  • the oil-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 3% to about 25% by weight, preferably in an amount of from about 5% to about 20% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
  • The“water-soluble organic sunscreen ingredient” means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in a liquid aqueous phase or which can be dissolved in colloidal form (for example in micellar form) in a liquid aqueous phase.
  • Non-limiting examples of water-soluble organic sunscreen ingredients useful in the invention include, for example, terephthalylidene dicamphor sulfonic acid, phenylbenzimidazole sulfonic acid, benzophenone-4, aminobenzoic acid (PABA), 4- Bis(polyethoxy)-para-aminobenzoic acid polyethoxyethyl ester (PEG-25 PABA), camphor benzalkonium methosulfate, methylene bis-benzotriazolyl tetramethylbutylphenol (Bisoctrizole), disodium phenyl dibenzimidazole tetrasulfonate (Bisdisulizole disodium), and tris-biphenyl triazine; their derivatives and corresponding salts; naphthalene bisimide derivatives such as those described in European patent application EP1990372 A2, the entire contents of which is hereby incorporated by reference; and cinnamido amine
  • the salts of the compounds that may be used according to the invention are chosen in particular from salts of alkali metals, for example sodium or potassium; salts of alkaline-earth metals, for example calcium, magnesium or strontium; metal salts, for example zinc, aluminum, manganese or copper; salts of ammonium of formula NH4+; quaternary ammonium salts; salts of organic amines, for instance salts of methylamine, dimethylamine, trimethylamine, triethylamine, ethylamine, 2- hydroxyethylamine, bis(2-hydroxyethyl)amine or tris(2-hydroxyethyl)amine; lysine or arginine salts.
  • Salts chosen from sodium, potassium, magnesium, strontium, copper, manganese or zinc salts are preferably used.
  • the sodium salt is preferably used.
  • the water-soluble organic sunscreen ingredient will be chosen from terephthalylidene dicamphor sulfonic acid, methylene bis-benzotriazolyl tetramethylbutylphenol, and mixtures thereof.
  • the water-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 0.1 % to about 10% by weight, preferably in an amount of from about 0.5% to about 8% by weight, and most preferably about 1 % to about 7% by weight, based on the total weight of the composition.
  • the suitable UV filter system of the present invention is preferably selected from the group of phenylbenzimidazole sulfonic acid, butyl methoxydibenzoylmethane, titanium dioxide, ethylhexyl triazone, terephthalylidene dicamphor sulfonic acid, octocrylene, homosalate, bis-ethylhexyloxyphenol methoxyphenyl triazine, silica (and) titanium dioxide, methylene bis-benzotriazolyl tetramethylbutylphenol (and) polyglyceryl-10 laurate, and combinations thereof.
  • the cosmetic composition of the present invention has an amount of UV filter system from about 0.1 % to about 50% by weight, preferably in an amount of from about 5% to about 40% by weight, more preferably about 5% to about 30% by weight, most preferably about 10% to about 30% by weight, based on the total weight of the composition.
  • the film forming polymer system of the present invention comprises hydrogenated polycyclopentadiene, acrylates copolymer and mixtures thereof.
  • the film forming polymer is present in an amount ranging from 0.5% to 5.0% by weight, preferably in an amount of from about 1 .0% to about 4.5% by weight, more preferably about 1 .5% to about 4.0% by weight, most preferably about 2.0% to about 3.5% by weight based on the total weight of the composition.
  • the film-forming polymer is a mixture of hydrogenated polycyclopentadiene and acrylates copolymer
  • the amount of hydrogenated polycyclopentadiene present is such mixture is from 0.5% to 3.5% by weight, based on the total weight of the composition
  • the amount of acrylates copolymer present in such mixture is from 0.5% to 3.5% by weight, based on the total weight of the composition.
  • the cosmetic composition of the present invention may further comprise additional polymers.
  • the suitable additional polymers of the present invention are selected from rheology modifier polymers and anionic polymers which may be water-soluble or water-dispersible at a pH of 7 and at room temperature (25°C). According to the present invention, the suitable polymers of the present invention could be as follows.
  • the rheology modifier polymers are pre-neutralized and preferably selected from taurate polymers.
  • Such polymers comprise an ionic monomer portion, 2-acrylamido-2-methylpropane sulfonic acid (AMPS), as well as a further, less polar monomer portion (vinylpyrrolidone or beheneth-25 methacrylate).
  • AMPS 2-acrylamido-2-methylpropane sulfonic acid
  • VPS 2-acrylamido-2-methylpropane sulfonic acid
  • These polymers are used as thickener and as stabilizer for oil-in-water emulsions and form extremely stable emulsions already at low concentrations.
  • these polymers can be used in conjunction with almost any oil phase, comprising silicone oils, hydrocarbons/waxes and ester oils.
  • taurate polymers are acrylates/vinyl isodecanoate crosspolymer (such as Stabylen 30), acrylates/Cio-3o alkyl acrylate crosspolymer (such as Pemulen TR1 and TR2), carbomers (Aqua SF-1 ), ammonium acryloyldimethyltaurate/VP copolymer (such as Aristoflex AVC), ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer (such as Aristoflex HMB), acrylates/ceteth-20 itaconate copolymer (such as Structure 3001 ), polyacrylamide (such as Sepigel 305), non-ionic thickener (such as Aculyn 46), or mixtures thereof.
  • acrylates/vinyl isodecanoate crosspolymer such as Stabylen 30
  • acrylates/Cio-3o alkyl acrylate crosspolymer such as Pemulen TR1 and TR
  • Acrylic polymer powders useful in the invention include, for example, acrylic polymer powders such as methyl methacrylate crosspolymer.
  • Anionic polymers may be polymers with anionic groups distributed along the polymer backbone.
  • Anionic groups which may include carboxylate, sulfonate, sulphate, phosphate, nitrate, or other negatively charged or ionizable groupings, may be disposed upon groups pendant from the backbone or may be incorporated in the backbone itself.
  • the anionic polymers may comprise at least one hydrophilic unit of olefinic unsaturated carboxylic acid type, and at least one hydrophobic unit exclusively of (Cio-C3o)alkyl ester of unsaturated carboxylic acid type.
  • the copolymers are chosen from the copolymers resulting from the polymerization of:
  • Ri is chosen from H or Chb or C2H5, providing acrylic acid, methacrylic acid, or ethacrylic acid monomers, and
  • Non-limiting examples of (Cio-C3o)alkyl esters of unsaturated carboxylic acids are for example chosen from lauryl acrylate, stearyl acrylate, decyl acrylate, isodecyl acrylate, dodecyl acrylate and the corresponding methacrylates, such as lauryl methacrylate, stearyl methacrylate, decyl methacrylate, isodecyl methacrylate and dodecyl methacrylate, and mixtures thereof.
  • crosslinked polymers may be chosen according to further exemplary embodiments.
  • such polymers may be chosen from polymers resulting from the polymerization of a mixture of monomers comprising:
  • R2 is chosen from H or CH3, R3 denoting an alkyl radical having from 12 to 22 carbon atoms, and
  • a crosslinking agent which is a well-known copolymerizable polyethylenic unsaturated monomer, such as diallyl phthalate, allyl (meth)acrylate, divinylbenzene, (poly)ethylene glycol dimethacrylate and methylenebisacrylamide.
  • acrylate/Cio-C3o alkyl acrylate copolymers such as the products PEMULEN TR1 , PEMULEN TR2, CARBOPOL 1382 and CARBOPOL EDT 2020 may be chosen.
  • Anionic polymers useful herein include, for example: polyacrylic acid; polymethacrylic acid; parboxyvinylpolymer; acrylate copolymers such as pcrylate/Cio- 30 alkyl acrylate crosspolymer, acrylic acid/vinyl ester copolymer/acrylatesninyl isodecanoate crosspolymer, acrylates/palmeth-25 acrylate copolymer, acrylate/steareth-20 itaconate copolymer, and acrylate/celeth-20 itaconate copolymer; sulfonate polymers such as polysulfonic acid, sodium polystyrene sulfonate, copolymers of methacrylic acid and acrylamidomethylpropane sulfonic acid, and copolymers of acrylic acid and acrylamidomethylpropane sulfonic acid; carboxymethycellulose; carboxy guar gum; copolymers of ethylene and maleic
  • the anionic polymers include, for example, Carbomer and CARBOPOL 980; acrylates/Cio-30 alkyl acrylate crosspolymer such as Pemulen TR-1 , PEMULEN TR-2, CARBOPOL 1342, CARBOPOL 1382, and CARBOPOL ETD 2020; sodium carboxymethylcellulose such as CMC series; and acrylate copolymer such Capigel; acrylates copolymer such as CARBOPOL Aqua SF- 1 as an aqueous dispersion, and acrylates crosspolymer-4 such as CARBOPOL Aqua SF-2 as an aqueous dispersion.
  • Carbomer and CARBOPOL 980 acrylates/Cio-30 alkyl acrylate crosspolymer such as Pemulen TR-1 , PEMULEN TR-2, CARBOPOL 1342, CARBOPOL 1382, and CARBOPOL ETD 2020; sodium carboxymethylcellulose such as CMC series; and acrylate copolymer such Capigel;
  • the anionic polymer of the invention is carbomer such as CARBOPOL 980.
  • Exemplary of non-ionic polymers could be as follows:
  • hydroxyethylcellulose for instance the product NATROSOL 250 HHR PC or NATROSOL 250 HHR CS;
  • celluloses modified with groups comprising at least one fatty chain examples that may be mentioned include:
  • hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups, or mixtures thereof, and in which the alkyl groups are preferably C8-C22, for instance the product NATROSOL Plus Grade 330 CS (C16 alkyls), or the product BERMOCOLL EHM 100; methyl hydroxyethylcellulose; methyl ethyl hydroxyethylcellulose, known as the product STRUCTURE CEL 8000 M; or hydroxypropyl cellulose, known as the product KLUCEL MF PHARM HYDROXYPROPYLCELLULOSE;
  • groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups, or mixtures thereof, and in which the alkyl groups are preferably C8-C22, for instance the product NATROSOL Plus Grade 330 CS (C16 alkyls), or the product BERMOCOLL E
  • alkylphenyl polyalkylene glycol ether groups such as the product Amercell Polymer HM-1500 (nonylphenyl polyethylene glycol (15) ether); or
  • hydroxypropyl guars such as hydroxypropyl guar and hydroxypropyl guars modified with groups comprising at least one fatty chain, such as the product Esaflor HM 22 (C22 alkyl chain), and the products RE210-18 (C14 alkyl chain) and RE205-1 (C20 alkyl chain).
  • composition of the invention may further comprise any usual cosmetically acceptable ingredient, which may be chosen especially from such as additional sunscreens, perfume/fragrance, preserving agents, solvents, actives, surfactants, fatty compounds, vitamins, fillers, silicones, pigments, buffering, masking and mixtures thereof.
  • Non-limiting example of preserving agent which can be used in accordance with the invention include phenoxyethanol.
  • Suitable fillers of the invention could be as examples of oil-absorbing fillers: mica, silica, kaolin, zea may (corn) starch, magnesium oxide, nylon-12, nylon- 66, cellulose, polyethylene, talc, talc (and) methicone, talc (and) dimethicone, perlite, sodium silicate, pumice, PTFE, polymethyl methacrylate, oryza sativa (rice) starch, aluminum starch octenylsuccinate, potato starch modified, alumina, silica silylate, calcium sodium borosilicate, magnesium carbonate, hydrated silica, dimethicone/vinyl dimethicone crosspolymer, sodium carboxylmethyl starch.
  • mica, silica, kaolin, zea may (corn) starch, magnesium oxide, nylon-12, nylon- 66, cellulose, polyethylene, talc, talc (and) methicone, talc (and) dimethi
  • composition of the present invention may comprise polymeric fillers such as polylactic acid.
  • Non-limiting suitable fatty compounds of the present invention include isononyl isonanoate, diisopropyl sebacate, isopropyl n-lauroylsarcosinate and stearyl alcohol.
  • Suitable solvents include, but are not limited to water, alcohols, glycols and polyols such as glycerin, water, caprylyl glycol, pentylene glycol, propylene glycol, butylene glycol, C12-15 alkyl benzoate and mixtures thereof.
  • the solvent is present in a concentration from about 15 to 100% by weight, or from about 20 to about 80% by weight, or from about 30 to about 70% by weight, or from about 35 to about 75% by weight, or preferably from about 40 to about 70% by weight, and more preferably from about 45 to about 65% by weight, including ranges and sub-ranges there between, based on the total weight of the combinations and/or compositions of the present disclosure.
  • Suitable additional actives include, but are not limited to, disodium EDTA, triethanolamine, and mixtures thereof.
  • Non-limiting examples of additional surfactants suitable for use are fatty acids, glyceryl esters in addition to glyceryl stearate, alkoxylated fatty alcohols, such as stearic acid, laureth-12, laureth-21 , glyceryl isostearate, disodium stearoyl glutamate, potassium cetyl phosphate, poloxamer 338, sodium methyl stearoyl taurate and mixtures thereof.
  • Exemplary of fat or oil materials include, but are not limited to, esters, fatty acids, synthetic oils, and hydrocarbons/paraffins, such as stearyl alcohol, myristic acid, palmitic acid silicones mineral oil, plant/vegetable oils, and mixtures thereof.
  • Non-limiting example of vitamins suitable for the composition of the present invention includes tocopherol.
  • silicones used in the composition of the present invention but not limited to are dimethicone and caprylyl methicone.
  • the additional ingredients may represent from 60% to 85%, such as from 60% to 82% or such as from 65 to 80% by weight of the total weight of the composition of the invention.
  • a non-limitative process for manufacturing the cosmetic composition according to the present invention comprise the following steps:
  • Example 1 A suitable composition according to the state of the art is as Example 1 and a suitable composition according to the present invention is as Examples 2 to 10, as follows:
  • Example 3 In order to evaluate the beneficiales to the consumer of the present invention (Example 3), a test was performed, in which interviews were conducted with 165 women users of tinted facial sunscreen from ages 18 to 55 with oily skin and combination skin. For such interviews, the performance and customer satisfaction were evaluated after 7 days of daily application of the inventive cosmetic composition.
  • the present cosmetic composition has a light texture (95% of volunteers), controlled the glow and oiliness of facial skin (around 92% of volunteers), and leaves the skin of the face with natural aspect throughout the day (94% of volunteers).
EP19752071.1A 2019-07-31 2019-07-31 Kosmetische zusammensetzung, verfahren zur herstellung der kosmetischen zusammensetzung und ihre verwendung Pending EP4003289A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2019/050311 WO2021016684A1 (en) 2019-07-31 2019-07-31 Cosmetic composition, process for manufacturing the cosmetic composition and its use

Publications (1)

Publication Number Publication Date
EP4003289A1 true EP4003289A1 (de) 2022-06-01

Family

ID=67551460

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19752071.1A Pending EP4003289A1 (de) 2019-07-31 2019-07-31 Kosmetische zusammensetzung, verfahren zur herstellung der kosmetischen zusammensetzung und ihre verwendung

Country Status (3)

Country Link
EP (1) EP4003289A1 (de)
BR (1) BR112021024030A2 (de)
WO (1) WO2021016684A1 (de)

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
US5624663A (en) 1987-08-28 1997-04-29 L'oreal Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates
US5237071A (en) 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
US5166355A (en) 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
FR2680683B1 (fr) 1991-08-29 1993-11-12 Oreal Composition cosmetique filtrante contenant un polymere filtre a structure hydrocarbonee et une silicone filtre.
ES2157268T5 (es) 1994-02-24 2004-12-01 SYMRISE GMBH & CO KG Preparados cosmeticos y dermatologicos que contienen acidos fenilen-1,4-bisbencimidazolsulfonicos.
US5601811A (en) 1994-08-01 1997-02-11 Croda, Inc. Substantive water-soluble cationic UV-absorbing compounds
GB9515048D0 (en) 1995-07-22 1995-09-20 Ciba Geigy Ag Sunscreen compositions
IT1284525B1 (it) 1996-09-13 1998-05-21 3V Sigma Spa Derivati di benzossazolo loro uso come stabilizzanti contro le radiazioni uv
DE19726184A1 (de) 1997-06-20 1998-12-24 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an lichtschutzwirksamen Benzotriazolderivaten
GB9715751D0 (en) 1997-07-26 1997-10-01 Ciba Geigy Ag Formulations
DE19746654A1 (de) 1997-08-13 1999-02-18 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE19755649A1 (de) 1997-12-15 1999-06-17 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE19828463A1 (de) 1998-06-26 1999-12-30 Basf Ag 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen
DE19855649A1 (de) 1998-12-03 2000-06-08 Basf Ag Dimere alpha-Alkyl-Styrolderivate als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE19857127A1 (de) 1998-12-11 2000-06-15 Basf Ag Oligomere Diarylbutadiene
IT1312374B1 (it) 1999-01-11 2002-04-15 3V Sigma Spa Associazioni di filtri solari e composizioni cosmetiche che licontengono
US6225467B1 (en) 2000-01-21 2001-05-01 Xerox Corporation Electroluminescent (EL) devices
DE10012408A1 (de) 2000-03-15 2001-09-20 Basf Ag Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil aminosubstituierte Hydroxybenzophenone enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE10012413A1 (de) 2000-03-15 2001-09-20 Basf Ag Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 4,4'-Diarylbutadiene enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
ITMI20012037A1 (it) 2001-10-02 2003-04-02 3V Sigma Spa Associazioni di filtri solari
DE10162844A1 (de) 2001-12-20 2003-07-03 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Bis-Resorcinyltriazinderivaten und Benzoxazol-Derivaten
WO2004006878A1 (en) 2002-07-10 2004-01-22 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
KR101187002B1 (ko) 2003-03-24 2012-09-28 시바 홀딩 인코포레이티드 대칭 트리아진 유도체
ES2582939T3 (es) 2003-12-17 2016-09-16 Basf Se Derivados de merocianina para uso cosmético
CN101023089B (zh) 2004-09-20 2013-11-06 莱雅公司 部花青砜的硅酸盐衍生物；包含它们的光防护组合物；作为uv过滤材料的应用
DE102004047286B4 (de) 2004-09-27 2006-11-23 Beiersdorf Ag Kosmetische Lichtschutzzubereitung auf Basis von Mikropigmenten
DE102004047283A1 (de) 2004-09-27 2006-04-13 Beiersdorf Ag O/W-Emulsionen mit anorganischen UV-Lichtschutzfilterpigmenten
DE102004047285A1 (de) 2004-09-27 2006-04-20 Beiersdorf Ag Organische Mikropigmente enthaltende kosmetische Lichtschutzemulsion
DE102004047288B4 (de) 2004-09-27 2006-11-30 Beiersdorf Ag Lichtschutzemulsion mit hohem Anteil an Lichtschutzfilterpigmenten
DE102004047282A1 (de) 2004-09-27 2006-04-20 Beiersdorf Ag W/O-Emulsion mit UV-Lichtschutzfilterpigmenten
DE102004047281A1 (de) 2004-09-27 2006-04-20 Beiersdorf Ag Lichtschutzkonzentrat mit organischen Mikropigmenten
US20060067960A1 (en) * 2004-09-30 2006-03-30 Russ Julio G Color cosmetic compositions
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
US9149664B2 (en) * 2007-01-31 2015-10-06 Akzo Nobel N.V. Sunscreen compositions
EP1990372A3 (de) 2007-05-09 2008-12-10 Ciba Holding Inc. Wasserlösliche UV-Filter
BR112012031957A2 (pt) * 2010-06-17 2016-08-23 Galaxy Surfactants Ltd composição de protetor solar de amplo espectro compreendendo 2-hidroxi sulfobetaína de cinamidoalquil amina
US9168211B2 (en) * 2014-03-28 2015-10-27 Johnson & Johnson Consumer Inc. Method of making an anhydrous, pigmented composition
CN107496276A (zh) * 2017-10-19 2017-12-22 佛山娇芙生物科技有限公司 一种具有防水功能的水包油型防晒霜及其制备方法

Also Published As

Publication number Publication date
BR112021024030A2 (pt) 2022-02-08
WO2021016684A1 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
CN107787222B (zh) 用于护肤组合物中的超吸收聚合物和淀粉粉末
US8628757B2 (en) Oleo-alcoholic anhydrous fluid screening composition comprising a lipophilic polyamide polycondensate
WO2020172725A1 (en) Sunscreen composition, use of a sunscreen composition, use of the liquid carnauba wax and process of manufacturing a sunscreen composition
FR2903599A1 (fr) Composition cosmetique a phase continue aqueuse comprenant au moins un polymere thermogelifiant, au moins un solvant organique volatil miscible dans l'eau et au moins un agent absorbant les radiations uv.
US20200261748A1 (en) Photoprotective compositions comprising an aqueous phase and a low melting point apolar wax
US20130243834A1 (en) Cross linked silicone copolmyer networks in a thickened aqueous phase
EP3307233B1 (de) Zusammensetzungen mit einem uv-schutz-mittel, einem hydrophilen vernetzten anionischen polymer, einem tensid mit einem hlb-wert grösser als oder gleich als 5 und einem silikoncopolymer
WO2014097972A1 (en) Cosmetic photoprotective compositions
AU2011212859B2 (en) Self adapting polymers for anhydrous sunscreen formulations
WO2017042227A1 (en) Anhydrous screening composition comprising a silicone fatty phase
WO2017189301A1 (en) Uv-a/uv-b sunscreen composition
EP3334401B1 (de) Sonnenschutzzusammensetzung mit hohem gehalt an fettlöslichen uv-filtern
US11033471B2 (en) Pigment compositions
US20220160735A1 (en) Anti-acne sunscreen composition, process for manufacturing an anti-acne sunscreen composition and use of an anti-acne sunscreen composition
EP3829533B1 (de) Sonnenschutzmittel, verwendung des sonnenschutzmittels und verfahren zur herstellung der sonnenschutzmittel
JP6739153B2 (ja) 疎水性変性イヌリン及びポリエーテル変性シリコーンを含む組成物
WO2021016684A1 (en) Cosmetic composition, process for manufacturing the cosmetic composition and its use
CN112236123A (zh) 定制色度防晒产品
JP2019099461A (ja) 二相サンケア組成物
WO2022067402A1 (en) Aqueous gel cosmetic sunscreen composition, process for manufacturing the aqueous gel cosmetic sunscreen composition and the use of the aqueous gel cosmetic sunscreen composition
WO2019119078A1 (en) Sun care composition
WO2020163928A1 (en) Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition
US20240000677A1 (en) Tinted cosmetic sunscreen composition, use of a tinted cosmetic sunscreen composition, and process for manufacturing a tinted cosmetic sunscreen composition
WO2019119077A1 (en) Sun care composition
WO2019210376A1 (en) Sunscreen compositions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220104

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ANDRIOLO, CYRUS

Owner name: L'OREAL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240130